Literature DB >> 27390012

Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter].

David E Cummings1.   

Abstract

Entities:  

Keywords:  Bariatric surgery; Biliopancreatic diversion; Diabetes; Diabetes surgery summit; Gastric bypass; Metabolic surgery; Randomised clinical trial; Randomised controlled trial; Randomised trial; Sleeve gastrectomy

Mesh:

Year:  2016        PMID: 27390012     DOI: 10.1007/s00125-016-4029-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  9 in total

Review 1.  Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.

Authors:  Simona Panunzi; Andrea De Gaetano; Annamaria Carnicelli; Geltrude Mingrone
Journal:  Ann Surg       Date:  2015-03       Impact factor: 12.969

2.  Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter].

Authors:  David E Cummings
Journal:  Diabetologia       Date:  2016-07-07       Impact factor: 10.122

3.  Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.

Authors:  David E Cummings; David E Arterburn; Emily O Westbrook; Jessica N Kuzma; Skye D Stewart; Chun P Chan; Steven N Bock; Jeffrey T Landers; Mario Kratz; Karen E Foster-Schubert; David R Flum
Journal:  Diabetologia       Date:  2016-03-17       Impact factor: 10.122

Review 4.  Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.

Authors:  L Sjöström
Journal:  J Intern Med       Date:  2013-02-08       Impact factor: 8.989

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Authors:  Francesco Rubino; David M Nathan; Robert H Eckel; Philip R Schauer; K George M M Alberti; Paul Z Zimmet; Stefano Del Prato; Linong Ji; Shaukat M Sadikot; William H Herman; Stephanie A Amiel; Lee M Kaplan; Gaspar Taroncher-Oldenburg; David E Cummings
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

7.  Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.

Authors:  Rachel L Batterham; David E Cummings
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

8.  Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes.

Authors:  Philip R Schauer; Geltrude Mingrone; Sayeed Ikramuddin; Bruce Wolfe
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

9.  Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.

Authors:  David E Cummings; Ricardo V Cohen
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

  9 in total
  1 in total

1.  Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter].

Authors:  David E Cummings
Journal:  Diabetologia       Date:  2016-07-07       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.